36C26026Q0957 LineItems A.xlsx

This is a line items spreadsheet detailing molecular diagnostic testing kits for a Federal Supply Schedule (FSS) contract with the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20. The contract number is 36C26026Q0957, with a period of performance spanning from December 1, 2026, through November 30, 2031, and is managed by contract specialist Eric Lingenfelter at Portland VAMC.

The contract covers four multiplex PCR-based molecular testing panel kits required for VA-owned molecular analyzers at Portland VAMC Microbiology Department: GI panel (892 kits per year), ME panel (51 kits per year), RP 2.1 panel (628 kits per year), and BCID2 panel (329 kits per year). These kits must provide FDA-cleared assays capable of simultaneously testing up to 20 respiratory pathogen targets, at least 20 GI pathogen targets (viruses, bacteria, and parasites), at least 40 blood culture identification targets, and up to 14 meningitis/encephalitis targets, with results delivered in one hour and minimal hands-on setup time of two minutes or less. The contract is structured as a base year (12/1/26–11/30/27) plus four one-year option periods, with the same kit quantities repeating annually. All items are classified under NAICS code 325413 (In-Vitro Diagnostic Substance Manufacturing) and PSC code 6550 (In Vitro Diagnostic Substances, Reagents, Test Kits and Sets), with pricing on a quantity-priced basis at percent discount of zero.